skip to main content About Administration & Leadership Campuses Departments Diversity Directory First Generation Students History News Academics Admissions ASPIR2E Current Students PharmD PharmD-MBA PhD Program Preceptors Residency Programs Community Community Education Partnerships & Initiatives Professional Education Research Pharmacy Practice Pharmaceutical Sciences Research Contacts Coronavirus RCOP Key COVID-19 Information Give Search Search Close Menu Collapsed content that can be toggled with the menu button. Apply Alumni Contact News About Administration & Leadership Campuses Departments Diversity Directory History Academics Admissions ASPIR2E Current Students PharmD PharmD-MBA PhD Program Preceptors Residency Programs Community Community Education Partnerships & Initiatives Professional Education Research Pharmacy Practice Pharmaceutical Sciences Research Contacts Alumni Apply Calendars Contact College Directory Texas A&M Directory Employment Give News Parking Press & Media Webmail Mansoor Khan Home Directory Mansoor A. Khan,PhD, RPh Mansoor A. Khan, PhD, RPh Vice Dean, College of Pharmacy College Station Campus Professor of Pharmaceutical Sciences Director, Formulations and Drug Delivery Core Laboratory Presidential Impact Fellow Education & Focus Areas Representative Publications Contact Texas A&M Irma Lerma Rangel College of Pharmacy Mail Stop 1114 159 Reynolds Medical Building College Station , TX 77843 mkhan@tamu.edu Phone: 979.436.0561 Fax: 979.436.0087 Education and Training St John's University, College of Pharmacy and Allied Health Professions, New York, PhD in Pharmaceutics (focus on industrial pharmacy and biopharmaceutics), 1992 Idaho State University, Masters of Science in Pharmaceutics (focus on physical pharmacy and drug delivery systems), 1988 Andhra University, India, Master of Science in Pharmaceutical Technology, 1984 Kakatiya University, India, Bachelor of Science in Pharmacy, 1982 Professional Certifications Professional Licensure Registered Pharmacist NY State Lic. # 44017 - Active Research Interests Formulations design and development Biopharmaceutics 3D printing (led the FDA New Drug Review Team that approved the first 3d-printed product on August 3, 2015) Awards, Recognition and Service American Association of Pharmaceutical Scientists (AAPS) elected chair of pharmaceutics and drug delivery (PDD) American Association of Pharmaceutical Scientists (AAPS) founding chair of formulations design and development (FDD) Editorial board of Pharmaceutical Technology, International Journal of Pharmaceutics, AAPSPharmsciTech, and the Drug Delivery and Translational Research FDA representative to European Medical Agency, EMA (pediatric working group, and pediatric formulations committee), WHO (generic quality and pediatric guidelines committee), USP (expert panel on dosage forms), FIP (program chair and keynote speaker), DOD/DARPA (continuous manufacturing advisory panel), Clinton HIV/AID panel (dosage forms expert), NIH (scientific advisory board of nanotech characterization lab, several study sections and PI in the FDA:NIH IAG), and NASA (PI of the recent FDA:NASA Research Cooperative Agreement) American Association of Pharmaceutical Scientists (AAPS) and American Association of Indian Pharmaceutical Scientists (AAiPS) Fellow FDA/CDER 2015 outstanding ANDA reviews award More than ten FDA/CDER Team Excellence Awards, Scientific Achievement Awards, and Exemplary Performance Awards Outstanding alumni award from St. Johns University, College of Pharmacy Excellence Award from Texas A&M University Health Science Center 2012 AAPS Research Achievement Award in Formulations Design and Development Representative Publications Woodcock, J., Khan, M., & Yu, L. X. (2012). Withdrawal of generic budeprion for nonbioequivalence. New England Journal of Medicine, 367(26), 2463-2465. Norman J, Madurawe RD, Moore CM, Khan MA, and Khairuzzaman A., A new chapter in pharmaceutical manufacturing: 3D printed drug products, Adv Drug Del Rev, 2016, S0169-409X(16)30077-1. Xu, X., Gupta, A., Al-Ghabeish, M., Calderon, S., and Khan, M*., Risk-based In Vitro Performance Assessment of Extended Release Abuse Deterrent Formulations , Int. J. Pharm., 2016. 16, 500 (1-2), 255-67. Hershenson S, Martin-Moe S, Khan MA, Jameel F (Editors), Biopharmaceutical Drug Product Development and Quality by Design, ISBN 978-1-4939-2316-8, New York: Springer, 2015, AAPS Press. Facebook Twitter Instagram Flickr RSS YouTube Back to top Institution Health Science Center Dentistry Medicine Nursing Pharmacy Public Health Information Calendars Contact Us Diversity Emergency Information Emergency Plans Maps & Parking Press & Media Title IX Clery Annual Reports Resources Directory eCampus Facilities Work Request Howdy Portal Information Technology Intranet Libraries Mental Health Resources Webmail Texas A&M University · Texas A&M University System · State of Texas · Open Records · Risk, Fraud & Misconduct Hotline · State Link Policy · Equal Opportunity / Nondiscrimination · Employment · Texas Veterans Portal · Security · Site Policies · Accessibility